文献速递产科母胎医学

首次分娩严重孕产妇病与后续分娩不良妊娠、分娩及新生儿结局风险

Severe maternal morbidity and risk of adverse pregnancy, delivery, and neonatal outcomes in the subsequent delivery.
PubMed 文献 · Am J Obstet Gynecol · 2025-11-21

在瑞典和不列颠哥伦比亚两个基于人群的队列中,首次分娩发生严重孕产妇病的母亲,其第二次分娩的围产期死亡/严重新生儿病复合结局风险升高(瑞典调整RR 1.88,95%CI 1.75-2.02;不列颠哥伦比亚调整RR 1.49,95%CI 1.24-1.79)。瑞典队列中第二次分娩的严重孕产妇病、子痫前期等风险亦升高。研究结果可用于有严重孕产妇病史女性的临床和生殖咨询。

要点

  • 首次分娩严重孕产妇病与第二次分娩围产期死亡/严重新生儿病复合结局风险升高相关。
  • 瑞典队列中第二次分娩严重孕产妇病风险为4.77倍,子痫前期风险为6.20倍。
  • 不列颠哥伦比亚队列调整估计方向与瑞典一致,多个结局达统计学显著。

核心结论

  • 在瑞典和不列颠哥伦比亚,首次分娩严重孕产妇病与后续分娩不良妊娠、分娩及子代结局风险升高相关。
  • 研究结果可指导有严重孕产妇病史女性的临床和生殖咨询。

研究设计与样本

  • 研究为两个基于人群的队列(瑞典和不列颠哥伦比亚),纳入首次和第二次分娩均有记录的母親。
  • 主要暴露为首次分娩严重孕产妇病(记录于妊娠、分娩或产后42天内)。
  • 结局为第二次分娩的妊娠和分娩并发症、子代严重新生儿病复合结局及出生后28天内围产期死亡(即死产或新生儿死亡)。
  • 采用多变量广义线性模型获得调整风险比和95%置信区间,并调整混杂因素。

主要发现

  • 与首次分娩无严重孕产妇病的母亲相比,首次分娩有严重孕产妇病者第二次分娩围产期死亡/严重新生儿病复合结局风险升高(瑞典调整RR 1.88,95%CI 1.75-2.02;不列颠哥伦比亚调整RR 1.49,95%CI 1.24-1.79)。
  • 瑞典队列中,首次分娩有严重孕产妇病者第二次分娩死产风险为1.59倍,新生儿死亡风险为1.65倍,严重新生儿病复合结局风险为1.95倍,婴儿死亡风险为1.69倍。
  • 瑞典队列中,与首次分娩无严重孕产妇病者相比,首次分娩有严重孕产妇病者第二次分娩严重孕产妇病风险为4.77倍,子痫前期风险为6.20倍,胎盘早剥、母亲感染、产前出血和产后出血风险约增加2倍。
  • 不列颠哥伦比亚队列中调整估计方向与瑞典一致,婴儿死亡、严重孕产妇病、子痫前期、妊娠期糖尿病、胎盘早剥、产前出血、产后出血以及择期和剖宫产分娩达统计学显著。

临床怎么用

  • 作者认为研究结果可指导有严重孕产妇病史女性的临床和生殖咨询。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Severe maternal morbidity is associated with substantially increased risks of adverse neonatal outcomes. However, few studies have assessed the association between severe maternal morbidity and adverse pregnancy, delivery, and perinatal outcomes in the subsequent delivery. OBJECTIVE: We aimed to investigate the association between severe maternal morbidity and its specific types in the first delivery and the risk of adverse pregnancy, delivery, and neonatal outcomes in the second delivery. STUDY DESIGN: We examined 2 population-based cohorts in Sweden and British Columbia, Canada, of mothers with both their first and second delivery recorded. The primary exposure was severe maternal morbidity in the first delivery (recorded during pregnancy, delivery or within 42 days postpartum). The outcomes were pregnancy and delivery complications, and offspring composite severe neonatal morbidity, and perinatal mortality (ie, stillbirths or neonatal deaths) within the first 28 days after birth, in the second delivery. We used multivariable generalized linear models to obtain adjusted risk ratios and 95% confidence intervals, adjusted for confounders. RESULTS: In both Sweden and British Columbia, women who experienced severe maternal morbidity in their first delivery had an increased risk of composite perinatal death/severe neonatal morbidity in the second delivery (Sweden: adjusted risk ratio, 1.88; 95% confidence interval, 1.75-2.02, British Columbia: adjusted risk ratio, 1.49; 95% confidence interval, 1.24-1.79), compared with mothers without severe maternal morbidity in the first delivery. In Sweden, second deliveries to women who had severe maternal morbidity in their first delivery were associated with a 1.59-times higher risk of stillbirth, a 1.65-times higher risk of neonatal mortality, a 1.95-times higher risk of composite severe neonatal morbidity, and 1.69-fold higher risk of infant mortality. In Sweden, compared with unaffected first delivery, severe maternal morbidity in the first delivery was associated with a 4.77-fold higher risk of severe maternal morbidity, 6.20-fold higher risk of preeclampsia, and an approximately 2-fold increased risk of placental abruption, maternal infection, antepartum hemorrhage, and postpartum hemorrhage in the second delivery. While in British Columbia, the adjusted estimates were in the same direction as in Sweden, statistical significance was reached for several outcomes, specifically, infant mortality, severe maternal morbidity, preeclampsia, gestational diabetes, placental abruption, antepartum hemorrhage, postpartum hemorrhage, and both elective and cesarean delivery in the second delivery. CONCLUSION: In both Sweden and British Columbia, Canada, severe maternal morbidity in the first delivery was associated with an increased risk of adverse pregnancy, delivery, and offspring outcomes in the subsequent delivery. Our findings can guide clinical and reproductive counseling for women with a history of severe maternal morbidity.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Tsamantioti E, Joseph KS, Ananth CV, et al. Severe maternal morbidity and risk of adverse pregnancy, delivery, and neonatal outcomes in the subsequent delivery. Am J Obstet Gynecol. 2025. PMID: 41276202. doi:10.1016/j.ajog.2025.11.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。